Check out our most popular compounded medications! Get Started
Phenylpropanolamine HCl 5 mg Oral Capsules are a solid dosage form designed for veterinary use. Each capsule consists of two halves, either gelatin or vegetarian-based, that encapsulate a precise 5 mg dose of the active ingredient, Phenylpropanolamine HCl. This medication is specifically formulated to be easy to administer to animals, ensuring accurate dosing and patient compliance.
Phenylpropanolamine is commonly used in veterinary medicine to treat conditions such as urinary incontinence in dogs, particularly those resulting from urethral sphincter hypotonus. It acts as a sympathomimetic agent, providing both alpha and beta adrenergic effects, which can help to tighten the urethral sphincter and prevent unwanted urine leakage. Additionally, Phenylpropanolamine may be prescribed to manage nasal congestion and as a decongestant in animals.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Phenylpropanolamine HCl 5 mg Oral Capsules are a solid dosage form, specifically designed for veterinary use, that offer a precise and controlled delivery of the active pharmaceutical ingredient, Phenylpropanolamine (PPA). These capsules are made from either gelatin or vegetarian-friendly materials, ensuring suitability for a range of dietary preferences. The encapsulation of the medication facilitates easy administration to animals, as the smooth outer shell aids in swallowing and masks any unpleasant taste of the active ingredient.
Phenylpropanolamine is primarily used in veterinary medicine for the management of urinary incontinence in dogs, particularly those suffering from urethral sphincter hypotonus. PPA acts as a sympathomimetic agent, which mimics the action of the sympathetic nervous system. It exerts its therapeutic effects by stimulating alpha-adrenergic receptors in the smooth muscle of the urethral sphincter, leading to increased sphincter tone and prevention of unwanted urinary leakage.
Animals with certain pre-existing conditions such as hypertension, hyperthyroidism, glaucoma, or heart disorders should be closely monitored while on this medication. Additionally, PPA may interact with other medications, so it is crucial to inform the prescribing veterinarian of all drugs the animal is currently taking. As with any medication, the potential for side effects exists, and any adverse reactions should be reported to the veterinarian immediately.
For optimal results, Phenylpropanolamine HCl 5 mg Oral Capsules should be administered as prescribed by a veterinarian, who will determine the appropriate dosage regimen based on the animal's specific condition and response to therapy. Consistent follow-up and monitoring are essential to ensure the safety and efficacy of the treatment. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is dedicated to providing the highest quality of care and is ready to assist with your veterinary pharmaceutical needs.
Phenylpropanolamine HCl (PPA) is a sympathomimetic agent that has been used for various indications in veterinary medicine, including as a decongestant and to treat urinary incontinence in dogs. When considering the use of Phenylpropanolamine HCl 5 mg Oral Capsules, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or the health of the patient.
PPA can interact with a variety of medications and substances. Concurrent use of monoamine oxidase inhibitors (MAOIs) can lead to hypertensive crises due to the additive sympathomimetic effects. It is advisable to avoid the use of PPA within two weeks of MAOI therapy. Similarly, caution should be exercised when PPA is administered with other sympathomimetic drugs, such as ephedrine or pseudoephedrine, as this may increase the risk of cardiovascular side effects like increased blood pressure and heart rate.
Tricyclic antidepressants (TCAs) can also potentiate the effects of sympathomimetics, leading to elevated blood pressure and arrhythmias. If PPA must be used with TCAs, close monitoring of the patient is recommended. Antihypertensive medications, particularly those that work by sympatholytic mechanisms, such as beta-blockers, may have reduced efficacy when used concurrently with PPA, as PPA may counteract their blood pressure-lowering effects.
Anesthetic agents, especially those that sensitize the myocardium to catecholamines, can increase the risk of arrhythmias when used with PPA. Patients undergoing surgery should inform their veterinarian about the use of PPA. Additionally, PPA may interact with other central nervous system stimulants, increasing the potential for nervousness, dizziness, or insomnia.
It is also important to consider the potential for interaction with over-the-counter medications and dietary supplements. For example, caffeine can enhance the stimulatory effects of PPA, and this combination should be used with caution. Patients should be advised to inform the veterinarian of all medications and supplements they are giving to their pet, including herbal products.
Phenylpropanolamine should be used with caution in animals with pre-existing medical conditions such as hypertension, hyperthyroidism, diabetes, heart disease, or glaucoma, as it may exacerbate these conditions. The safety of PPA in pregnant or lactating animals has not been well established, so its use in these populations should be carefully considered and discussed with a veterinarian.
Due to the potential for drug interactions and the serious nature of some of these interactions, it is crucial for prescribers to thoroughly review the patient's medication history before prescribing PPA. Monitoring for adverse effects and adjusting doses as necessary is important for the safe use of this medication. If you have any questions or concerns regarding the use of Phenylpropanolamine HCl 5 mg Oral Capsules for your pet, please reach out to us at Bayview Pharmacy for further assistance.
Phenylpropanolamine HCl, commonly referred to as phenylpropanolamine or PPA, is a sympathomimetic agent that has been widely used in veterinary medicine. The primary mechanism of action of phenylpropanolamine is its ability to stimulate the alpha-adrenergic receptors in the body. By activating these receptors, PPA induces the contraction of smooth muscle tissues, which can be particularly beneficial in managing conditions such as urinary incontinence in dogs, often caused by a lack of muscle tone in the urethral sphincter. The drug's action helps to tighten the sphincter, thereby reducing episodes of involuntary urine leakage.
In addition to its effects on the urinary sphincter, phenylpropanolamine also has a mild stimulant effect on the central nervous system and can lead to an increase in blood pressure by causing vasoconstriction. This vasoconstrictive action can be useful in treating hypotension. However, it is important to monitor blood pressure in animals being treated with PPA, as excessive vasoconstriction can lead to hypertension, which may require adjustment of the dosage or discontinuation of the medication.
The formulation of Phenylpropanolamine HCl 5 mg Oral Capsules is designed to provide a precise dosage of the active ingredient in a solid dosage form. The capsules are composed of two gelatin or vegetarian shells that enclose the medication. This form of encapsulation ensures that the drug is protected from degradation before administration and facilitates easy swallowing for the animal. The use of capsules also allows for a controlled release of the medication into the animal's system, providing a consistent therapeutic effect.
The specific dosage and administration schedule should be determined by a veterinarian based on the individual needs of the animal. Regular monitoring for side effects, such as increased heart rate, hypertension, and behavioral changes, is recommended. Additionally, PPA should be used with caution in animals with pre-existing heart disease, glaucoma, and hyperthyroidism, among other conditions.
For any questions regarding the use of Phenylpropanolamine HCl 5 mg Oral Capsules for veterinary patients, or to discuss the suitability of this medication for a particular animal, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide guidance and support to ensure the safe and appropriate use of this medication.
Phenylpropanolamine HCl (PPA) 5 mg oral capsules are commonly used in veterinary medicine to treat urinary incontinence in dogs. This medication helps to tighten the bladder sphincter muscles, which can help to control urine leakage.
These capsules should be given to your pet orally, by mouth, as directed by a veterinarian. They can be given with or without food, but consistency in administration (with or without food) should be maintained.
No, this medication may not be appropriate for all pets. It's essential to consult with a veterinarian before using it, as some pets with pre-existing conditions or those taking certain medications may experience adverse effects.
Like all medications, PPA may cause side effects, including increased heart rate, hypertension, irritability, and restlessness. If you notice any adverse reactions or behavioral changes in your pet, contact your veterinarian immediately.
Yes, PPA can interact with other medications. It is especially important to disclose all medications and supplements your pet is currently taking to your veterinarian to avoid potential drug interactions.
If you miss a dose, administer it as soon as you remember. However, if it's almost time for the next scheduled dose, skip the missed dose and continue with the regular dosing schedule. Do not double up on doses to compensate for the missed one.
Store the capsules in a cool, dry place, away from light and moisture. Keep the medication out of reach of children and pets.
If you suspect your pet has received an overdose of PPA, seek emergency veterinary medical treatment immediately. Symptoms of overdose can include increased heart rate, agitation, and seizures.
The shelf life of the capsules is typically indicated on the label or packaging. Always check the expiration date before administration and do not use beyond that date. For more information, consult with your veterinarian or the pharmacy providing the medication.
No, medications specifically formulated for animals should not be taken by humans. The dosages, formulations, and regulations for veterinary drugs are distinct from those intended for human use.
Yes, Phenylpropanolamine HCl is a controlled substance and requires a prescription from a licensed veterinarian for use. It is illegal and unsafe to use this medication without a prescription specifically for your pet.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
